ReviewLymphology2009
Ocular lymphatics: state-of-the-art review.
Review in Lymphology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
50 citing papers in PubMed, 68 citations in OpenAlex.
- Ocular Lymphatics in Health and Disease.Diagnostics (Basel, Switzerland) · 2026Review
- Limbal Epithelial Stem Cells in Review: Immune and Lymphangiogenic Privilege and Their Clinical Relevance.Cells · 2026Review
- Systemic Envenomation via Ocular Route from a Neurotoxic Snake Venom Ophthalmia--A Case Report.Journal of acute medicine · 2025Article
- Managing Persistent Pupillary Membranes With Surgery or Medication: A Report of Three Cases.Cureus · 2025Article
- Metastatic conjunctival melanoma: a multicentre international study.The British journal of ophthalmology · 2025Article
- Cytokines in Allergic Conjunctivitis: Unraveling Their Pathophysiological Roles.Life (Basel, Switzerland) · 2024Review
- Novel discovery of a lymphatic bridge connecting Schlemm's canal to limbal and conjunctival lymphatic pathway.The ocular surface · 2023Article
- Radius-Maumenee syndrome: A case series with a long-term follow-up.Clinical case reports · 2023Article
- Clinical features and treatment outcomes of progressive uveal melanoma.Archive of clinical cases · 2023Article
- Ocular Lymphatic and Glymphatic Systems: Implications for Retinal Health and Disease.International journal of molecular sciences · 2022Review
- Protein and polypeptide mediated delivery to the eye.Advanced drug delivery reviews · 2022Review
- Review
- Patients presenting with metastases: stage IV uveal melanoma, an international study.The British journal of ophthalmology · 2022Article
- Progress on Brain and Ocular Lymphatic System.BioMed research international · 2022Review
- Review
- Lipid-Based Nanocarriers as Topical Drug Delivery Systems for Intraocular Diseases.Pharmaceutics · 2021Review
- The Cellular Composition of the Uveal Immune Environment.Frontiers in medicine · 2021Review
- Aqueous humor induces lymphatic regression on the ocular surface.The ocular surface · 2020Article
- An ocular glymphatic clearance system removes β-amyloid from the rodent eye.Science translational medicine · 2020Article
- Role of Endogenous Regulators of Hem- And Lymphangiogenesis in Corneal Transplantation.Journal of clinical medicine · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
Research involving the lymphatic system has experienced an exponential progression during the past decade largely because of advancement of modern technology and discovery of several lymphatic specific molecules. The eye provides an excellent site for lymphatic studies due to its accessible location and the unique feature of tissue heterogeneity--while some tissues are lymphatic-rich, others are lymphatic-free or -inducible. This review provides an update on our current understanding of ocular lymphatics and possible associated eye diseases.
Indexed as
Identifiers
19725271PMC4725303W2341493083What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.